Pan American League of Associations for Rheumatology Recommendations for the Treatment of Psoriatic Arthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/38561190/

HLA-B27 positivity in a large miscegenated population of 5,389,143 healthy blood marrow donors in Brazil (2023)
https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-023-00302-6

Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis (2023)
https://www.nature.com/articles/s41584-023-01034-z

HLA-B27 did not protect against COVID-19 in patients with axial spondyloarthritis – data from the ReumaCov-Brasil Registry (2023)
https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-023-00340-0

Dactylitis in psoriatic arthritis: a histologic description (2022)
https://academic.oup.com/rheumatology/article-abstract/61/4/1737/6296850?redirectedFrom=fulltext&login=false

Fecal calprotectin as a biomarker of microscopic bowel inflammation in patients with spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35855677/

COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data (2022)
https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-022-00268-x

Brazilian recommendations for the use of nonsteroidal anti-inflammatory drugs in patients with axial spondyloarthritis (2021)
https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-020-00160-6

Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis (2021)
https://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-021-00219-y

The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019 (2020)
https://link.springer.com/epdf/10.1186/s42358-020-0116-2?author_access_token=D2WUdCP7psZzyaRqhv_uq2_BpE1tBhCbnbw3BuzI2RNd14If9DDRGmg6Wa9oBLQOxSvGGpyjcf0_81AWEQs7S3sisSbOl29x4QeElGG80TpNFI9G0s8Fc4G9Yk4MPRX6NwyRBHafHc631hn-cmjLGQ%3D%3D

IL-22 increases the production of sFRP3 by FLS in inflammatory joint diseases (2020)
https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2020000900608&lng=en&nrm=iso&tlng=en

Quality of life in spondyloarthritis: analysis of a large Brazilian cohort. (2016)
https://www.ncbi.nlm.nih.gov/pubmed/27267330

Evaluation of performance of BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) in a Brazilian cohort of 1,492 patients with spondyloarthritis: data from the Brazilian Registry of Spondyloarthritides (RBE). (2015)
https://www.ncbi.nlm.nih.gov/pubmed/25542672

Profile of the use of disease modifying drugs in the Brazilian Registry of Spondyloarthritides. (2014)
https://www.ncbi.nlm.nih.gov/pubmed/24878789

Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort. (2014)
https://www.ncbi.nlm.nih.gov/pubmed/25458023

Assessment of fatigue in a large series of 1492 Brazilian patients with Spondyloarthritis. (2014)
https://www.ncbi.nlm.nih.gov/pubmed/24884480

Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis. (2013)
https://www.ncbi.nlm.nih.gov/pubmed/23858049

Enteropathic arthritis in Brazil: data from the Brazilian Registry of Spondyloarthritis. (2013)
https://www.ncbi.nlm.nih.gov/pubmed/24477722

Ethnic influence in clinical and functional measures of Brazilian patients with spondyloarthritis. (2012)
https://www.ncbi.nlm.nih.gov/pubmed/22045839

Gender characterization in a large series of Brazilian patients with spondyloarthritis. (2012)
https://www.ncbi.nlm.nih.gov/pubmed/22203094

Low prevalence of renal, cardiac, pulmonary, and neurological extra-articular clinical manifestations in spondyloarthritis: analysis of the Brazilian Registry of Spondyloarthritis. (2012)
https://www.ncbi.nlm.nih.gov/pubmed/22641592

Effect of age at disease onset in the clinical profile of spondyloarthritis: a study of 1424 Brazilian patients. (2012)
https://www.ncbi.nlm.nih.gov/pubmed/22510473